Document:

Form of Performance Share Award

 Exhibit 10.01f 
 FORM OF 2009 
 PERFORMANCE AWARD 
 UNDER THE 
 2002 PRAXAIR, INC. 
 LONG TERM INCENTIVE PLAN 
 Effective as of February 24, 2009 (the “Date of Grant”),
[                    ] (the “Participant”) is hereby granted the following Performance Award under the 2002 Praxair, Inc. Long Term
Incentive Plan (the “Plan”), subject to the terms and conditions of the Plan, which are incorporated herein by reference, and those set forth below. Capitalized terms used herein and not defined shall have the meanings set forth in the
Plan, as the same may be amended from time to time. For purposes of this Award, Praxair, Inc. (the “Company”) and its Affiliates and Subsidiaries are collectively referred to herein as “Praxair”. In the event of any conflict
between this Award and the Plan, the Plan shall control. 
  

	1.	Award of Performance Share Units. The Participant is hereby granted a Performance Award of [        ] notional “Performance Share
Units” (the “Award”). A Performance Share Unit is a bookkeeping entry which is intended to be equal in value to a single share of Company Stock. For purposes of this Award, [        ]
Performance Share Units is considered the Participant’s “Target Amount.” Except as otherwise provided herein, the payment due in settlement of the Participant’s vested Award shall be made in the form of shares of Company Stock,
with the number of shares payable determined by reference to the Company’s cumulative earnings per share (“EPS”) growth for the three-year period commencing on January 1, 2009 and ending on December 31, 2011 (the
“Performance Period”) as set forth below. For purposes of this Award, EPS shall be determined on the basis of the Company’s Net Income, as described in the Praxair, Inc. Plan for Determining Performance-Based Awards under
Section 162(m) (the “Praxair 162(m) Plan”), divided by the diluted number of shares of Company Stock then outstanding. The diluted number of shares outstanding is computed in accordance with FASB Statement No. 128, Earnings
per Share (or any successor statement thereto), and reported in the Company’s quarterly and annual Consolidated Financial Statements and the related Notes. 

  

	2.	Vesting of Award; Treatment upon Termination of Service. 

  

	 	a.	Vesting Generally. Except as otherwise provided in this Section 2, this Award shall vest on the third anniversary of the Date of Grant, provided that: (i) the Participant
has remained continuously employed by Praxair at all times from the Date of Grant through the third anniversary of the Date of Grant; and (ii) the Company’s cumulative EPS growth for the Performance Period meets the minimum threshold
performance target for payout set forth in Section 3.a. Payment with respect to such vested Award shall be determined and made in accordance with Section 3.a. 

  

	 	b.	Death or Disability. Notwithstanding any provision of this Section 2 to the contrary, if after the Date of Grant, but prior to the third anniversary of the Date of Grant:

  

	 	(i)	the Participant’s employment by Praxair terminates by reason of the Participant’s death; or 

  

	 	(ii)	the Participant becomes Totally and Permanently Disabled while employed by Praxair; 

 this Award shall become immediately vested and payment with respect to such vested Award shall be determined and made in accordance with Section 3.b. For purposes of this Award, a Participant shall be
“Totally and Permanently Disabled” if the Participant is determined by Praxair to be unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result
in death or can be expected to last for a continuous period of not less than 12 months. 
  

	 	c.	Termination by Action of Praxair Other than for Cause, or Termination After Attaining Certain Age and Service Requirements. Notwithstanding any provision of this Section 2 to
the contrary, in the event the Participant’s employment by Praxair terminates after the first anniversary of the Date of Grant, but prior to the third anniversary of the Date of Grant, by reason of the Participant’s:

  

	 	(i)	termination of employment by action of Praxair other than for cause; or 

  

	 	(ii)	termination of employment with Praxair, other than for cause, after: (a) attaining age 65; (b) attaining age 62 and completing at least ten (10) years of employment
with Praxair; or (c) having accumulated 85 points, where each year of the Participant’s age and each year of employment with Praxair, count for one point, 

 this Award shall vest on the third anniversary of the Date of Grant, provided that the Company’s
cumulative EPS growth for the Performance Period meets the minimum threshold performance target for payout set forth in Section 3.a. Payment with respect to such vested Award shall be determined and made in accordance with Section 3.a.

  

	 	d.	Change in Control of the Company. Notwithstanding any provision of this Section 2 to the contrary, this Award shall become immediately vested upon the occurrence of a Change in
Control of the Company prior to the third anniversary of the Date of Grant, and payment with respect to such vested Award shall be determined and made in accordance with Section 3.c. 

  

	 	e.	Materially Adverse and Unforeseen Market Conditions. Notwithstanding any provision of this Section 2 to the contrary, in the event that upon the completion of the Performance
Period, it is determined by the Committee that the Company’s cumulative EPS growth for the Performance Period: 

  

	 	(i)	does not meet the minimum threshold performance target for payout set forth in Section 3.a as a result of materially adverse and unforeseen market conditions beyond the control
of the Company and its employees, officers and directors occurring during the Performance Period; and 

  

	 	(ii)	exceeds the average cumulative earnings per share growth for the companies included in the Materials Sector (Global Industry Classification Standard 15) of the S&P 500 index for
the same Performance Period; 

 then, to the extent not previously vested pursuant to Sections 2.b. or 2.d., or forfeited in
connection with the Participant’s termination of employment with Praxair pursuant to Section 2.f.(i), this Award shall vest on the third anniversary of the Date of Grant unless otherwise determined by the Committee in its sole discretion,
and payment with respect to such vested Award will be made in accordance with Section 3.d. 
  

	 	f.	Forfeiture of Award. 

  

	 	(i)	In the event the Participant’s employment with Praxair terminates for any reason other than those specifically set forth in Sections 2.b. or 2.c. prior to the third anniversary
of the Date of Grant and before the occurrence of a Change in Control of the Company, this Award shall be immediately forfeited. 

  

	 	(ii)	Absent the occurrence of a Change in Control of the Company occurring prior to the third anniversary of the Date of Grant, and to the extent not previously forfeited pursuant to
Section 2.f.(i), this Award shall be immediately forfeited as of the end of the Performance Period if either: (1) the Company’s cumulative EPS growth for the Performance Period does not meet the minimum threshold performance target
for payout set forth in Section 3.a and the Committee determines that Section 2.e. does not apply; or (2) the Committee determines that Section 2.e. does apply but exercises its discretion pursuant to such Section not to vest the
Award. 

  

	 	(iii)	In the event this Award is forfeited for any reason, no payment shall be made in settlement of the Award. 

  

	3.	Payment of Vested Award. 

  

	 	a.	Determination of Amount of Payment. Except as otherwise provided in this Section 3, the number of shares of Company Stock payable in settlement of the Participant’s vested
Award shall be determined by reference to the Company’s cumulative EPS growth for the Performance Period in accordance with the table below, and may range from 0% to 150% of the Participant’s Target Amount. Each Performance Share Unit is
equivalent to one share of Company Stock. Payouts will be interpolated if the cumulative EPS growth attained for the Performance Period falls between the Threshold and Maximum percentages specified in the table, and will be rounded down to the
nearest whole number of shares. The payment of shares pursuant to this Section 3.a. will be made as soon as practicable after the date the Award becomes vested, but in no event later than March 15, 2012. 

  

					
	 Cumulative EPS Growth
 For Performance Period
	 	 EPS Target (based on
 January 1, 2009 EPS
 of $[    ])

	 	 Payout as Percentage of
 Target Amount

	 [    ]%                  
	 	$[    ] or less	 	[    %]

	 	 b.
	 Determination of Amount of Payment Following Death or Total and Permanent Disability. In the event the Participant
becomes vested in this Award by reason of his or her death or Total and Permanent Disability in accordance with Section 2.b., this Award shall be settled by payment of a number of shares of Company Stock equal to the Participant’s Target
Amount as soon as practicable following the date the Award becomes vested, but in no event later than March 15th of the year following the year
in which the Award becomes vested. 

  

	 	c.	Determination of Amount of Payment Following a Change in Control of the Company. In the event the Participant becomes vested in this Award as the result of the occurrence of a
Change in Control of the Company in accordance with Section 2.d., this Award shall be settled by payment of the Participant’s Target Amount as soon as practicable after the occurrence of such Change in Control, but in no event later than
March 15th of the year following the year in which the Change in Control of the Company occurred. Notwithstanding any provision of this Award to the contrary, any amounts paid in settlement of this Award pursuant to this Section 3.c. shall
be paid in shares of Company Stock or such other form having a value equivalent to the Participant’s Target Amount, as may be authorized by the Committee in its sole discretion. 

  

	 	d.	Determination of Amount of Payment Following Materially Adverse and Unforeseen Market Conditions. In the event this Award becomes vested as the result of materially adverse and
unforeseen market conditions pursuant to Section 2.e., this Award shall be settled by payment of a number of shares of Company Stock equal to 50% of the Participant’s Target Amount as soon as practicable after the date the Award becomes
vested, but in no event later than March 15, 2012. 

  

	4.	Other Terms and Conditions. It is understood and agreed that the Award of Performance Share Units evidenced hereby is subject to the following terms and conditions:

  

	 	a.	Rights of Participant. The Participant shall have no right to transfer, pledge, hypothecate or otherwise encumber the Award. Prior to the payment of shares of Stock in satisfaction
of this Award, the Participant shall have none of the rights of a stockholder of the Company with respect to the Award, including, but not limited to, voting rights and the right to receive or accrue dividends. 

  

	 	b.	No Right to Continued Employment. This Award shall not confer upon the Participant any right with respect to continuance of employment by Praxair nor shall this Award interfere with
the right of Praxair to terminate the Participant’s employment. 

  

	 	c.	No Right to Future Awards. The selection of recipients of Performance Awards under the Plan is determined annually on the basis of several factors, including job responsibilities
and anticipated future job performance. The Participant’s selection to receive this Award shall in no way entitle him/her to receive, or otherwise obligate Praxair to provide the Participant, any future Performance Award or other award under
the Plan or otherwise. 

  

	 	d.	Transferability. The Participant shall not be permitted to sell, assign, transfer, pledge or otherwise encumber this Award. 

  

	 	e.	Cancellation of Award. Notwithstanding any other provision of this Award, the Committee may, in its sole discretion, cancel, rescind, suspend, withhold, or otherwise limit or
restrict this Award, and/or recover any gains realized by the Participant in connection with this Award, in the event any actions by the Participant are determined by the Committee to (a) constitute a conflict of interest with Praxair,
(b) be prejudicial to Praxair’s interests, or (c) violate any non-compete agreement or obligation of the Participant to Praxair, any confidentiality agreement or obligation of the Participant to Praxair, Praxair’s applicable
policies, or the Participant’s terms and conditions of employment. 

  

	5.	Tax Withholding. Where required by law, no later than the date of payment of the Award, the Participant shall pay to Praxair an amount sufficient to allow Praxair to satisfy its tax
withholding obligations applicable to the Award. To this end, the Participant shall either: 

  

	 	a.	pay Praxair the amount of tax to be withheld (including through payroll withholding); 

  

	 	b.	deliver to Praxair other shares of Company Stock owned by the Participant prior to such date having a fair market value, as determined by the Committee, not less than the amount of
the withholding tax due, which either have been owned by the Participant for more than six (6) months or were not acquired, directly or indirectly, from the Company; 

  

	 	c.	make a payment to Praxair consisting of a combination of cash and such shares of Stock; or 

  

	 	d.	request that Praxair cause to be withheld a number of shares of Stock otherwise due the Participant hereunder having a then fair market value sufficient to discharge all applicable
withholding taxes (but no greater than such amount). 

	6.	Qualified Performance-Based Compensation. It is intended that all payments under this Award constitute “qualified performance-based compensation” within the meaning of
Section 162(m) of the Code and the Praxair 162(m) Plan. This Award is to be construed and administered in a manner consistent with such intent. 

  

	7.	References. References herein to rights and obligations of the Participant shall apply, where appropriate, to the Participant’s legal representative or estate without regard to
whether specific reference to such legal representative or estate is contained in a particular provision of this Award. 

  

	8.	Governing Law. This Award shall be governed by and construed in accordance with the laws of Connecticut, without giving effect to principles of conflict of laws.

 IN WITNESS WHEREOF, the Company has caused this instrument to be executed by its proper officer hereunto duly authorized, as of the day and
year first hereinabove written. 
  

			
	Praxair, Inc.
		
	By:	 	  

		 	Sally A. Savoia
		 	Vice President, Human ResourcesForm of Executive Severance Compensation Agreement

 Exhibit 10.02 
 Praxair, Inc. 
 Severance Compensation Agreement 
 [date] 
 NAME 
 ADDRESS 
 Dear
Mr.             : 
 The Board of Directors (the “Board”) of
Praxair, Inc. (“Praxair”) recognizes that the possibility of a Change in Control of Praxair exists, and the uncertainty and questions which it may raise among management may result in the departure or distraction of management personnel to
the detriment of Praxair or its majority-owned subsidiaries (hereinafter to be referred to collectively as the “Company”). 
 The
Board has determined that appropriate steps should be taken to reinforce and encourage the continued attention and dedication of members of the Company’s management, including yourself, to their assigned duties without distraction in the face
of potentially disturbing circumstances arising from a possible Change in Control of Praxair. 
 In order to induce you to remain in the
employ of the Company and in consideration of both your continued service to the Company and your execution of a Nondisclosure, Nonsolicitation and Noncompetition agreement in the form provide to you by Praxair, Praxair agrees that you shall receive
the severance benefits set forth in this Severance Compensation Agreement (“Agreement”) in the event your employment with the Company is terminated subsequent to a Change in Control under the circumstances described below in Subsection 2a.
This Agreement amends and supersedes in all respects, all prior Severance Compensation Agreements previously entered into between you and the Company. 
 1. Definitions. 
 a. “Change in Control” means the occurrence of any
one of the following events with respect to Praxair: 
  

	 	(i)	 individuals who, on January 1, 2009, constitute the Board (the “Incumbent Directors”) cease for any reason to constitute at least a majority of the
Board, provided that any person becoming a director subsequent to January 1, 2009, whose election or nomination for election was approved 

	 	 
by a vote of at least two-thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the Praxair proxy statement in
which such person is named as a nominee for director, without objection to such nomination) shall be an Incumbent Director; provided, however, that no individual elected or nominated as a director of Praxair initially as a result of an
actual or threatened election contest with respect to directors or any other actual or threatened solicitation of proxies or consents by or on behalf of any person other than the Board shall be deemed an Incumbent Director;

  

	 	(ii)	any “person” (as such term is defined in Section 3(a)(9) of the Securities Exchange Act of 1934 (the “Exchange Act”) and as used in Sections 13(d)(3) and
14(d)(2) of the Exchange Act) is or becomes a “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of Praxair representing 20% or more of the combined voting power of Praxair’s
then outstanding securities eligible to vote for the election of the Board (the “Praxair Voting Securities”); provided, however, that the event described in this Subsection 1a(ii) shall not be deemed to be a Change in Control
by virtue of any of the following acquisitions: (A) by Praxair or any of its subsidiaries, (B) by any employee benefit plan sponsored or maintained by Praxair or any of its subsidiaries, (C) by any underwriter temporarily holding
securities pursuant to an offering of such securities, or (D) pursuant to a Non-Qualifying Transaction (as defined in Subsection 1a(iii)); 

  

	 	(iii)	 the consummation of a merger, consolidation, statutory share exchange or similar form of corporate transaction involving Praxair or any of its subsidiaries that
requires the approval of Praxair’s stockholders, whether for such transaction or the issuance of securities in the transaction (a “Business Combination”), unless immediately following such Business Combination: (A) more than 50%
of the total voting power of (x) the corporation resulting from such Business Combination (the “Surviving Corporation”), or (y) if applicable, the ultimate parent corporation that directly or indirectly has beneficial ownership
of 100% of the voting securities eligible to elect directors of the Surviving Corporation (the “Parent Corporation”), is represented by Praxair Voting Securities that were outstanding immediately prior to such Business Combination (or, if
applicable, shares into which such Praxair Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportion as the voting power of such Praxair Voting
Securities among the holders thereof immediately prior to the Business Combination, (B) no person (other than any employee benefit plan sponsored or maintained by the Surviving Corporation or the Parent Corporation), is or becomes the
beneficial owner, directly or indirectly, of 20% or more of the total voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving 

  

 2 

	 	 
Corporation) and (C) at least a majority of the members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the
Surviving Corporation) were Incumbent Directors at the time of the Board’s approval of the execution of the initial agreement providing for such Business Combination (any Business Combination which satisfies all of the criteria specified in
(A), (B) and (C) above shall be deemed to be a “Non-Qualifying Transaction”); or 

  

	 	(iv)	the stockholders of Praxair approve a plan of complete liquidation or dissolution of Praxair or a sale or disposition of all or substantially all of Praxair’s assets.

 Notwithstanding the foregoing, a Change in Control shall not be deemed to occur solely because any person acquires
beneficial ownership of more than 20% of the Praxair Voting Securities as a result of the acquisition of Praxair Voting Securities by Praxair which reduces the number of Praxair Voting Securities outstanding; provided, that if after
such acquisition by Praxair such person becomes the beneficial owner of additional Praxair Voting Securities that increases the percentage of outstanding Praxair Voting Securities beneficially owned by such person, a Change in Control shall then
occur. 
 b. “Code” shall mean the Internal Revenue Code of 1986, as amended. 
 c. “Date of Termination” shall mean 
  

	 	(i)	in case your employment is terminated for Total Disability, thirty (30) days after Notice of Termination is given (provided that you shall not have returned to the full-time
performance of your duties during such thirty (30) day period), 

  

	 	(ii)	in case your employment is terminated due to your death, your date of death; 

  

	 	(iii)	in case your employment is Terminated for Cause, the date on which the Board adopts the resolution described in Subsection l of Section 1 of this Agreement

  

	 	(iv)	in all other cases, the date specified in the Notice of Termination (which shall not be less than thirty (30) nor more than forty-five (45) days, respectively, from the
date such Notice of Termination is given). 

 d. “Good Reason for Resignation” shall mean,
without your express written consent, any of the following: 
  

	 	(i)	 a change in your status or position with the Company which in your reasonable judgment does not represent a promotion from your status or position immediately prior
to the Change in Control, or the assignment to you of any duties or responsibilities or diminution of duties or responsibilities which in your reasonable judgment are inconsistent with 

  

 3 

	 	 
your status or position with the Company in effect immediately prior to the Change in Control, it being understood that any of the foregoing in connection
with termination of your employment due to your death or Total Disability or your Termination for Cause shall not constitute Good Reason for Resignation; 

  

	 	(ii)	a reduction by the Company in the annual rate of your base salary as in effect immediately prior to the date of the Change in Control or as the same may be increased from time to
time thereafter, unless such reduction is part of a policy, program or arrangement that is applicable on a nondiscriminatory basis to you and other similarly situated executives employed by the Company or its successors; 

  

	 	(iii)	the Company relocates your principal office to a location where the distance between your primary residence and your new principal office is more than 50 miles greater than the
distance between your primary residence and your principal office location as of the date immediately prior to the Change in Control; 

  

	 	(iv)	the failure by the Company to continue in effect compensation or benefit plans in which you participate, which in the aggregate provide you compensation opportunities and benefits
at least substantially equivalent to those prior to the Change in Control, but excluding any reduction in compensation opportunities and/or benefits that is part of a policy, program or arrangement that is applicable on a nondiscriminatory basis to
you and other similarly situated executives employed by the Company or its successors; 

  

	 	(v)	the failure of the Company to obtain a satisfactory agreement from any Successor (as defined in Subsection 4a hereof) to assume and agree to perform this Agreement, as contemplated
in Subsection 4a hereof; 

  

	 	(vi)	any purported termination of your employment which is not effected pursuant to a Notice of Termination satisfying the requirements hereof; for purposes of this Agreement, no such
purported termination shall be effective for any purpose except to constitute a Good Reason for Resignation. 

 Notwithstanding the foregoing, Good Reason for Resignation shall not exist unless you provide the Company with a Notice of Termination not later than 60 days after the occurrence of the event giving rise to your Good Reason for Resignation
and the Company fails to remedy such condition to your reasonable satisfaction within 30 days of such notice. 
 e.
“Incentive Compensation” means any compensation, variable compensation, incentive compensation, bonus or award paid or payable under an Incentive Compensation Plan. 
  

 4 

 f. “Incentive Compensation Plan” shall mean any plan, program or
arrangement for the payment of variable compensation, bonus, benefits or awards maintained by the Company, in which awards are paid in cash including, but not limited to, the 2002 Praxair, Inc. Variable Compensation Plan, or any successor plan
thereto, in which you are eligible to participate. 
 g. “Notice of Termination” shall mean a written notice
as provided in Section 9 hereof. 
 h. “Pension Plan” shall mean the Praxair Pension Plan, as it may be
amended prior to a Change in Control. 
 i. “Pension Program” shall mean the Pension Plan plus any excess or
supplemental pension plans maintained by the Company. 
 j. “Account-Based Participant” shall mean a
participant in the Pension Plan accruing an Account-Based benefit under the Pension Plan. 
 k. “Traditional-Design
Participant” shall mean a participant in the Pension Plan accruing a benefit under the Pension Plan other than an Account-Based benefit. 
 l. “Termination for Cause” shall mean termination of your employment upon your willfully engaging in conduct demonstrably and materially injurious to the Company, monetarily or otherwise, provided
that there shall have been delivered to you a copy of a resolution duly adopted by the unanimous affirmative vote of the entire membership of the Board at a meeting of the Board called and held for such purpose (after reasonable notice to you and an
opportunity for you, together with your counsel, to be heard before the Board), finding that in the good faith opinion of the Board you were guilty of the conduct set forth and specifying the particulars thereof in detail. 
 For purposes of this Subsection, no act, or failure to act, on your part shall be deemed “willful” unless done, or omitted to be
done, by you not in good faith and without reasonable belief that your action or omission was in the best interest of the Company. Any act or failure to act based upon authority given pursuant to a resolution duly adopted by the Board or based upon
the advice of counsel for the Company shall be conclusively presumed to be done or omitted to be done by you in good faith and in the best interests of the Company. 
 m. “Total Disability” shall mean that based on objective medical evidence, as the result of an illness or injury, you
cannot perform the essential functions of your regular job for a period of six months or more, with or without an accommodation; and you are under the “regular and appropriate care” of a physician. “Regular and Appropriate Care”
means that you are being treated by a physician as often as is medically required, and are receiving care that conforms to generally accepted medical standards for treating the sickness or injury; is consistent with the stated severity of the
medical condition to effectively treat this illness or injury; and is provided by a physician whose specialty or experience is the most appropriate for the disability according to generally accepted medical practices. 
  

 5 

 n. “Variable Compensation Year” means a calendar or fiscal plan year of
any Incentive Compensation Plan. 
 2. Compensation Upon Termination. Following a Change in Control, you shall be entitled to the
following benefits: 
 a. Termination Benefits. If, during the term of this Agreement (as defined in Section 3),
your employment by the Company is terminated subsequent to a Change in Control and under circumstances that would qualify as a “separation from service” under Code Section 409A, (a) by the Company other than a Termination for
Cause, or (b) by you with Good Reason for Resignation, then you shall be entitled to the benefits provided below, without regard to any contrary provision of any plan: 
  

	 	(i)	Accrued Salary. The Company shall pay you within the timeframe required under applicable law, your full base salary and vacation pay accrued through your Date of Termination
at the rate in effect at the time the Notice of Termination is given (or at the rate in effect immediately prior to the Change in Control, if such amounts was higher). 

  

	 	(ii)	Accrued Incentive Compensation. The Company shall pay you, not later than thirty (30) days following your Date of Termination, the amount of your accrued Incentive
Compensation, determined as the sum of: 

 (a) if your Date of Termination is after the end of a Variable Compensation Year,
but before Incentive Compensation for said Variable Compensation Year has been paid, the Company shall pay you as Incentive Compensation for that Variable Compensation Year an amount equal to your actual Incentive Compensation payment for such
Variable Compensation Year, determined using both your and the Company’s actual performance for such Variable Compensation Year, but in no event shall your individual performance factor for purposes of such determination be less than 1.0; plus

 (b) if your Date of Termination is other than the first day of a Variable Compensation Year, the Company shall pay you, as Incentive
Compensation for the Variable Compensation Year in which your Date of Termination occurs, an amount equal to your target Incentive Compensation payment for such Variable Compensation Year (or if higher, your target Incentive Compensation payment for
the year in which the Change in Control occurred), multiplied by a fraction, the numerator of which is the total number of days which have elapsed in the current Variable Compensation Year to your Date of Termination, and the denominator of which is
three hundred sixty-five (365). 
 If there is more than one Incentive Compensation Plan, your accrued Incentive Compensation under each Plan
shall be determined individually. 
  

 6 

	 	(iii)	Insurance Coverage. The Company shall arrange to provide you (and your dependents, if applicable) with life, accident and health insurance benefits substantially equivalent
to those which you are receiving or entitled to receive immediately prior to the Change in Control. Such insurance benefits shall be provided to you for the longer of (x) twenty four (24) months after your Date of Termination, or
(y) the period during which such insurance benefits would have been provided to you, as a terminated employee, under the applicable life insurance, medical, health and accident plans of the Company in effect immediately prior to the Change in
Control. Benefits provided pursuant to this Subsection for the first twenty four (24) months after your Date of Termination shall be provided at no cost to you and any benefits provided after such twenty four (24) month period shall be
provided to you on the same financial terms and conditions as provided for under the respective plans. 

 Should it be
determined that any of the medical benefits to be provided to you under this Subsection 2a(iii) could be included in your gross income for federal, state or local tax purposes, then the following shall apply: 
 (a) If you are at least age 48 with at least eight (8) years of service with the Company on your Date of Termination, then you shall participate in
the Company’s retiree medical benefit plans as if you retired from the Company on your Date of Termination with eligibility for such plans, except that the Company shall provide such medical coverage at no cost to you for two (2) years
following your Date of Termination and thereafter, you shall participate therein on the same terms as other retired employees (to the extent these benefits are provided by the Company’s self-insured plan, any reimbursements for claims incurred
shall be made as soon as practicable, but in no event can they be made later than the end of the calendar year following the calendar year in which the claim was incurred); 
 (b) If you are not at least age 48 or do not have at least eight (8) years of service upon your Date of Termination, you will no longer continue to
participate in the Company’s medical benefit plans, except for COBRA, and (i) if you elect to receive COBRA benefits, the Company shall provide you with such benefits at no cost to you for the first eighteen (18) months following your
loss of medical coverage, and thereafter, (ii) the Company shall, for the subsequent six (6) months, purchase for you, at its cost, a policy of medical insurance providing benefits substantially similar to the benefits you would have
received under the Company’s medical benefit plans. 
  

	 	(iv)	Retirement Benefits. 

  

	 	A.	If you are a Traditional-Design Participant, the provisions of this Subsection 2a(iv)A shall apply to you. 

  

 7 

 The Company shall pay you, at the time you are entitled to be paid a retirement pension under the
Pension Program, a retirement pension equal to the greater of (x) an amount computed in accordance with the terms of the Pension Program in effect immediately prior to the Change in Control and as if those terms were in effect on your Date of
Termination, or (y) an amount computed in accordance with the terms of the Pension Program in effect immediately prior to your Date of Termination, in either case less the amount of retirement pension actually to be paid to you under the
Pension Program. In computing the amounts of your retirement pension under clauses (x) and (y) of this Subsection, three (3) years shall be added to your actual age and to your actual Company service credit under the Pension Program
so that your retirement pension under clauses (x) and (y) will be the amount it would have been if you had been three (3) years older than you actually were, and had three (3) years more Company service credit than you actually
had, on your Date of Termination. 
 If for any reason, the benefits under this Subsection cannot be paid under the tax-qualified portion of
the Pension Program, the Company shall pay such benefits to you in a lump sum, not later than thirty (30) days after your Date of Termination, calculated under such one of the following options as would produce the highest lump sum payment:
(a) calculated under the same factors (interest rate and mortality) as lump sum payments were made under the Company’s Supplemental Retirement Income Plan and Equalization Benefit Plan in effect immediately prior to a Change in Control;
(b) calculated under the same factors (interest rate and mortality) as total lump sum payments are made under the Company’s Supplemental Retirement Income Plan and Equalization Benefit Plan, or other similar plans, as in effect on your
Date of Termination; or (c) calculated under the same factors (interest rate and mortality) as lump sum payments would have been calculated under the Company’s Supplemental Retirement Income Plan and Equalization Benefit Plan on your Date
of Termination, if such factors were determined using the same methodology as such plans used prior to the Change in Control. 
  

	 	B.	If you are an Account-Based Participant the provisions of this Subsection 2a(iv)B shall apply to you. 

 To provide benefits to you which are equivalent to the benefits you would have received under the Pension Program for the three (3) years following
your Date of Termination, the Company shall pay you an amount equal to four percent (4%) of your Compensation (as defined in the Pension Plan but without regard to the limitations of Code Section 401(a)(17) and including amounts 

  

 8 

 
deferred by you under any Praxair compensation deferral program) paid for the year prior to the Change in Control or the year prior to your Date of
Termination, whichever is greater, multiplied by three (3). Such amount shall be paid to you not later than the thirtieth (30th) day following
your Date of Termination. 
  

	 	 (v)
	 Severance Payment. The Company shall pay as severance pay to you, not later than the thirtieth (30th) day following your Date of Termination, a lump sum severance payment (the “Severance Payment”) equal to three (3) times the sum of the
following: 

 (a) the greater of your annual base compensation which was payable to you by the Company immediately prior to
your Date of Termination and your annual base compensation which was payable to you by the Company immediately prior to a Change in Control, whether or not such annual base compensation was includible in your gross income for federal income tax
purposes; plus 
 (b) the amount of your target Incentive Compensation payment for the Variable Compensation Year in which the Change in
Control occurs, or if higher, your target Incentive Compensation payment for the Variable Compensation Year in which your Date of Termination occurs. 
  

	 	(vi)	Excise Tax. 

 (a) For purposes of this Subsection
2a(vi), the following terms shall have the following meanings: 
  

	 	(I)	Payment shall mean any payment or distribution (or acceleration of benefits) by the Company to or for your benefit (whether paid or payable or distributed or distributable
(or accelerated) pursuant to the terms of this Agreement or otherwise, but determined without regard to any additional payments required under this Subsection 2a(vi)). In addition, Payment shall mean the amount of income deemed to be received by you
as a result of the acceleration of the exercisability of any of your options to purchase stock of the Company or the acceleration of the lapse of any restrictions on performance stock or restricted stock of the Company held by you or the
acceleration of any payment from any deferral plan of the Company. 

  

	 	(II)	Excise Tax shall mean the excise tax imposed by Section 4999 of the Code, or any interest or penalties incurred by you with respect to such excise tax.

  

	 	(III)	 Income Tax shall mean all taxes other than the Excise Tax (including any interest or penalties imposed with respect to 

  

 9 

	 	 
such taxes) including, without limitation, any income and employment taxes imposed by any federal (including (i) FICA and Medicare taxes, and
(ii) the tax resulting from the loss of any federal deductions or exemptions which would have been available to you but for receipt of the Payment), state, local, commonwealth or foreign government. 

 (b) In the event it shall be determined that the amount of the Payments payable to you would constitute an “excess parachute payment,” within
the meaning of Section 280G of the Code, subject to the Excise Tax, and the present value of such Payments (calculated in a manner consistent with that set forth in the applicable regulations promulgated under Section 280G of the Code) is
equal to or less than 105% of the threshold at which such amount becomes an “excess parachute payment,” then the amount of the Payments payable to you under this Agreement shall be reduced (a “Reduction”) to the extent necessary
so that no portion of such Payments payable to you is subject to the Excise Tax. In the event a Reduction is required, the payments to be reduced will be determined in a manner which has the least economic cost to you and, to the extent the economic
cost is equivalent, will be reduced in the inverse order of when payment would have been made to you until the Reduction is achieved. 
 (c)
In the event it shall be determined that the amount of the Payments payable to you is more than 105% greater than the threshold at which such amount becomes an “excess parachute payment,” then the amount of the Payments payable to you
shall not be reduced in any way and you shall be entitled to receive an additional payment from the Company (a “Gross-Up Payment”) in an amount such that after payment by you of Income Tax and Excise Tax imposed upon the Gross-Up Payment,
you retain an amount of the Gross-Up Payment equal to the Excise Tax imposed upon the Payment. 
 (d) All determinations required to be made
under this Subsection 2a(vi), including whether and when a Gross-Up Payment or a Reduction is required and the amount of such Gross-Up Payment or Reduction and the assumptions to be utilized in arriving at such determination, shall be made by the
public accounting or actuarial consulting firm that is retained by the Company (the “Firm”) which shall provide detailed supporting calculations both to the Company and to you within fifteen (15) business days of the receipt of notice
from you that there has been a Payment, or such earlier time as is requested by the Company (collectively, the “Determination”). In no event may the Firm retained by the Company be serving as accountant, auditor or consultant for the
individual, entity or group affecting the Change in Control. All fees and expenses of the Firm shall be borne solely by the Company. Any Gross-Up Payment, as determined pursuant to this Subsection 2a(vi), shall be paid by the Company to you within
thirty (30) days after your receipt of the 

  

 10 

 
Determination. If the Firm determines that no Excise Tax is payable by you, you may request the Firm to furnish you with a written opinion that failure to
report the Excise Tax on your applicable federal income tax return would not result in the imposition of a negligence or similar penalty. The Determination by the Firm shall be binding upon the Company and you. As a result of the uncertainty in the
application of Section 4999 of the Code at the time of the Determination, it is possible that Gross-Up Payments which will not have been made by the Company should have been made (an “Underpayment”), consistent with the calculations
required to be made hereunder. In the event that the Company exhausts its remedies pursuant to Subsection 2a(vi)(e) and you thereafter are required to make payment of any Excise Tax or Income Tax, the Firm shall determine the amount of the
Underpayment that has occurred and any such Underpayment shall be promptly paid by the Company to you or for your benefit. 
 (e) You shall
notify the Company in writing of any claim by the Internal Revenue Service that, if successful, would require the payment by the Company of the Gross-Up Payment or the Underpayment. Such notification shall be given as soon as practicable but no
later than ten (10) business days after you are informed in writing of such claim and shall apprise the Company of the nature of such claim and the date on which such claim is requested to be paid. You shall not pay such claim prior to the
expiration of the 30-day period following the date on which you give such notice to the Company (or such shorter period ending on the date that any payment of taxes with respect to such claim is due). If the Company notifies you in writing prior to
the expiration of such period that it desires to contest such claim, you shall: 
  

	 	(I)	give the Company any information reasonably requested by the Company relating to such claim, 

  

	 	(II)	take such action in connection with contesting such claim as the Company shall reasonably request in writing from time to time, including, without limitation, accepting legal
representation with respect to such claim by an attorney reasonably selected by the Company, 

  

	 	(III)	cooperate with the Company in good faith in order effectively to contest such claim, and 

  

	 	(IV)	 permit the Company to participate in any proceeding relating to such claim; provided, however, that the Company shall bear and pay directly all costs and expenses
(including additional interest and penalties) incurred in connection with such contest and shall indemnify and hold you harmless, on an after-tax basis, for any Excise Tax or Income Tax imposed as a result of 

  

 11 

	 	 
such representation and payment of costs and expenses. Without limitation on the foregoing provisions of this Subsection 2a(vi)(e), the Company shall control
all proceedings taken in connection with such contest and, at its sole option, may pursue or forego any and all administrative appeals, proceedings, hearings and conferences with the taxing authority in respect of such claim and may, at its sole
option, either direct you to pay the tax claimed and sue for a refund or contest the claim in any permissible manner, and you agree to prosecute such contest to a determination before any administrative tribunal, in a court of initial jurisdiction
and in one or more appellate courts, as the Company shall determine; provided further, that if the Company directs you to pay such claim and sue for a refund, the Company shall advance the amount of such payment to you on an interest-free basis and
shall indemnify and hold you harmless, on an after-tax basis, from any Excise Tax or Income Tax imposed with respect to such advance or with respect to any imputed income with respect to such advance; and provided further, that any extension of the
statute of limitations relating to payment of taxes for your taxable year with respect to which such contested amount is claimed to be due is limited solely to such contested amount. Furthermore, the Company’s control of the contest shall be
limited to issues with respect to which a Gross-Up Payment would be payable hereunder and you shall be entitled to settle or contest, as the case may be, any other issue raised by the Internal Revenue Service or any other taxing authority.

 (f) If, after the receipt by you of an amount advanced by the Company pursuant to Subsection 2a(vi)(e), you become
entitled to receive, and receive, any refund with respect to such claim, you shall (subject to the Company’s complying with the requirements of Subsection 2a(vi)(e)) promptly pay to the Company the amount of such refund (together with any
interest paid or credited thereon after taxes applicable thereto). If, after the receipt by you of an amount advanced by the Company pursuant to Subsection 2a(vi)(e), a determination is made that you shall not be entitled to any refund with respect
to such claims and the Company does not notify you in writing of its intent to contest such denial of refund prior to the expiration of thirty (30) days after such determination, then such advance shall be forgiven and shall not be required to
be repaid and the amount of such advance shall be offset, to the extent thereof, the amount of the Gross-Up Payment required to be paid. 
 (g) To ensure compliance with Section 409A of the Code, in no event will the Gross-Up Payment be made later than the end of your taxable year after the taxable year in which you pay the Excise Tax. 
  

 12 

	 	(vii)	No Duty to Mitigate. You shall not be required to mitigate the amount of any payment provided for in this Section 2 by seeking other employment or otherwise, nor shall
the amount of any payment or benefit hereunder be reduced by any compensation earned by you as the result of employment by another employer or by retirement benefits after your Date of Termination, provided, however, should you become reemployed in
a job which (a) offers medical plan benefits which are equal to or greater than the medical plan benefits provided to you under Subsection 2a(iii), and (b) such medical plan benefits are offered to you at no cost, you shall no longer be
eligible to receive medical plan benefits under this Agreement. 

  

	 	(viii)	Six Month Delay. Notwithstanding any provision of this Agreement to the contrary, and only to the extent necessary to comply with Section 409A of the Code, if, as of
your Date of Termination, you are considered a Specified Employee (as such term is defined in Section 409A of the Code) the payments due you which are described in Subsections 2a(ii), 2a(iii), 2a(iv), 2a(v) and 2a(vi) shall not be paid until
the expiration of the six month period immediately following your Date of Termination (the “Delay Period”) and, at the conclusion of such Delay Period, any amounts that would have been payable during such Delay Period under these
Subsections but for this Subsection 2a(viii), shall be paid in a single sum. 

 b. Payments While
Disabled. During any period prior to your Date of Termination and during the term of this Agreement (as defined in Section 3) that you are unable to perform your full-time duties with the Company, whether as a result of your Total
Disability or as a result of a physical or mental disability that is not total or is not permanent and therefore is not a Total Disability, you shall continue to receive your base salary at the rate in effect at the commencement of any such period
(reduced by the amount of any short term disability or salary continuation benefits payable on account of your disability under any Company plan, program or arrangement), together with all other compensation and benefits that are payable or provided
under the Company’s benefit plans, including its disability plans. After your Date of Termination, your benefits shall be determined in accordance with the Company’s Pension Program, insurance and other applicable programs. The
compensation and benefits, other than salary, payable or provided pursuant to this Subsection 2b shall be the greater of (x) the amounts computed under the Pension Program, disability benefit plans, insurance and other applicable programs in
effect immediately prior to the Change in Control and (y) the amounts computed under the Pension Program, disability benefit plans, insurance and other applicable programs in effect at the time the compensation and benefits are paid.

 c. Payments if Terminated for Cause or by You Without Good Reason for Resignation. If, during the term of this
Agreement (as defined in Section 3), your employment by the Company shall be Terminated for Cause or by you other than with Good Reason for Resignation, the Company shall pay you within the timeframe required under applicable law, your full
base salary and accrued vacation pay through your Date of Termination, at the rate in effect at the time Notice of Termination is given. Thereafter the Company shall have no further obligation to you under this Agreement. Any other benefits due to
you and/or beneficiaries shall be determined in accordance with the Company’s Pension Program and other applicable retirement, benefit and insurance programs, then in effect. 
  

 13 

 d. After Death. If, during the term of this Agreement (as defined in
Section 3), your employment by the Company is terminated by reason of your death, the Company shall pay to your estate within the timeframe required under applicable law, your full base salary and accrued vacation pay through your Date of
Termination, at the rate then in effect. Any other benefits due to you, your estate and/or beneficiaries shall be determined in accordance with the Company’s Pension Program and other applicable retirement, benefit and insurance programs, then
in effect. 
 e. Payments Conditioned Upon Release. In addition
to all other requirements set forth in this Agreement, as a condition of receiving the termination benefits described in Subsections 2a and 2b (other than the payment of accrued salary under Subsection 2a(i)) you must first sign a general release in
the form attached hereto as Exhibit A (or such other mutually acceptable form), which shall be provided to you no later than two (2) days after your Date of Termination and must be executed by you, become effective and not be revoked by you by
the twenty-eighth (28th) day following the date you receive such general release. If such release does not become effective within that
timeframe or you revoke such release or otherwise repudiate it or breach its terms at any time, all termination benefits payable under Subsections 2a (other than accrued salary under Subsection 2a(i)) and 2b shall be suspended and you shall
immediately repay to the Company any such termination benefits that we previously paid to you or on your behalf. Such suspended/repaid termination benefits shall only be paid if they are found to be payable by a final decision of a court. In the
absence of such a finding, the suspended/repaid termination benefits shall be forfeited. 
 3. Term of Agreement. This Agreement shall
become effective as of January 1, 2009, if, and only if, you have executed and returned to Praxair the Nondisclosure, Nonsolicitation and Noncompetition agreement previously provided to you, and shall thereafter continue in effect through
December 31, 2009; provided, however, that commencing on January 1, 2010 and each January 1 thereafter, the term of this Agreement shall automatically be extended for one additional year unless, not later than September 30 of the
preceding year, the Company or you shall have given notice that it or you do not wish to extend this Agreement. Notwithstanding any such notice by the Company or you not to extend this Agreement, if a Change in Control shall have occurred:

 (a) during the original or extended term of this Agreement or, 
 (b) after this Agreement has been terminated, but within twelve months after such notice to terminate the Agreement is given by the
Company, 
 the attempted termination of the Agreement shall be deemed ineffective and this Agreement shall continue in effect. In any event, the term of
this Agreement shall expire on the second (2nd) anniversary of the date of the Change in Control. Notwithstanding any provision in this Agreement to the contrary, this Agreement shall terminate immediately if your employment is terminated by
you or the Company prior to a Change in Control, or if your position is changed prior to a Change in Control so that you are no longer an officer of the Company entitled by virtue of your position to have this Agreement and, in either case, the
provisions of subsection (b) of this Section 3 shall not be applicable. 
  

 14 

 4. Successors; Binding Agreement. 
 a. Successors of the Company. The Company will require any Successor to all or substantially all of the business and/or assets of
the Company to expressly assume and agree, by an agreement in form and substance reasonably satisfactory to you, to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such
succession had taken place. Failure of the Company to obtain such assent at least five business days prior to the time a person becomes a Successor (or where the Company does not have at least five business days advance notice that a person may
become a Successor, within three business days after having notice that such person may become or has become a Successor) shall constitute Good Reason for Resignation by you and, if a Change in Control has occurred or thereafter occurs, shall
entitle you immediately to the benefits provided in Subsection 2a hereof upon delivery by you of a Notice of Termination which the Company, by executing this Agreement, hereby assents to. For purposes of this Agreement, “Successor” shall
mean any person that purchases all or substantially all of the assets of the Company or the Surviving Corporation (and Parent Corporation, if applicable) or obtains or succeeds to, or has the practical ability to control (either immediately or with
the passage of time), the Company’s business directly, by merger or consolidation, or indirectly, by purchase of voting securities of the Company or by acquisition of rights to vote voting securities of the Company or otherwise, including but
not limited to any person or group that acquires the beneficial ownership or voting rights described in Subsection 1a(ii). 
 b. Your Successor. This Agreement shall inure to the benefit of and be enforceable by your personal or legal representatives, executors, administrators, successors, heirs, distributees, devises and legatees. If you should die
following your Date of Termination while any amount would still be payable to you hereunder if you had continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to your
devisee, legatee or other designee or, if there is no such designee, to your estate. 
 5. Relationship to Other Agreements. To the
extent that any provision of any other agreement between the Company and you shall limit, qualify or be inconsistent with any provision of this Agreement, then for purposes of this Agreement, while the same shall remain in force, the provision of
this Agreement shall control and such provision of such other agreement shall be deemed to have been superseded, and to be of no force or effect, as if such other agreement had been formally amended to the extent necessary to accomplish such
purpose. 
 6. Nature of Payments. All payments to you under this Agreement shall be considered either payments in consideration of
your continued service to the Company or severance payments in consideration of your past service to the Company. 
  

 15 

 7. Validity. The invalidity or unenforceability of any provision of this Agreement shall not
affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect. 
 8.
Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument. 
 9. Notice. Any purported termination of your employment by the Company or by you following a Change in Control shall be communicated to the other
party by a Notice of Termination. A Notice of Termination shall indicate the specific termination provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination
of your employment under the provision so indicated. For the purpose of this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered or mailed by
United States registered mail, return receipt requested, postage prepaid, addressed to the respective addresses set forth on the first page of this Agreement, provided that all notices to the Company shall be directed to the attention of the Board
with a copy to the Secretary of Praxair or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt. 
 10. Fees and Expenses. Praxair shall pay all reasonable legal fees and related expenses incurred by you as a result of your termination following
a Change in Control or by you in seeking to obtain or enforce any right or benefit provided by this Agreement (including all reasonable fees and expenses, if any, incurred in contesting or disputing any such termination or incurred by you in seeking
advice in connection therewith); provided that such fees are incurred no later than the end of the second calendar year after the year of your Date of Termination. Any such payments will be made as soon as practicable but in no event can they be
made later than the end of the calendar year following the calendar year in which the fee or expense was incurred. 
 11. Survival.
The respective obligations of, and benefits afforded to, the Company and you as provided in Sections 2, 4, 5, 6, 10 and 11 of this Agreement shall survive termination of this Agreement. 
 12. Miscellaneous. No provision of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to
in writing and signed by you and such officer as may be specifically designated by the Board. No waiver by either party hereto at any time of any breach by the other party hereto of, or compliance with, any condition or provision of this Agreement
to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. No agreements or representations, oral or otherwise, express or implied, with respect to
the subject matter hereof have been made by either party which are not expressly set forth in this Agreement. 
 13. Governing Law.
The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of Connecticut. 
  

 16 

 14. Amendment. No amendment to this Agreement shall be effective unless in writing and signed by
both you and the Company. 
 15. Duplicate Payments. If the national laws of any country require any payments to you by the Company or
any of its subsidiaries or affiliates as a result of your termination due to a Change in Control, the amount of any such payment shall be deducted from any payment due to you under this Agreement. It is expressly stated as the Company’s intent
under this Agreement that the amount you receive from the Company as a result of your termination due to a Change in Control shall be limited to the amount calculated as provided in this Agreement. This Section does not limit your ability, without
offsetting reductions to the Company’s payment obligation, to receive government payments for which you may be eligible as a result of the termination of your employment. 
 16. Tax Withholding. The Company shall withhold from all amounts payable under this Agreement any federal, state, local or other taxes that the
Company, in its sole discretion, determines to be appropriate under applicable law. 
 If this letter sets forth our agreement on the subject
matter hereof, kindly sign and return to the Company the enclosed copy of this letter which will then constitute our agreement on this subject. 
  

			
	Sincerely,
	
	PRAXAIR, INC.
		
	By:	 	  

		 	[                                        
    ]
	Title:	 	Chairman and Chief Executive Officer

  

	
	Agreed to this day of             , 2008
	
	  

  

 17 

 EXHIBIT A 
 GENERAL RELEASE 
 1. In consideration of the promises and termination benefits payable pursuant to the
Praxair, Inc. Severance Compensation Agreement between me and Praxair, Inc., and dated as of [INSERT], 2008, I, [INSERT NAME], for myself and on behalf of my heirs, assigns, successors, executors and administrators, hereby fully and irrevocably
release and discharge Praxair, Inc., its predecessors, successors, parents, affiliates, divisions and subsidiaries and, in their capacities as such, all of their present, past, and future directors, officers, employees, representatives, attorneys,
insurers, reinsurers, agents and assigns (collectively, “Praxair”), from any and all manner of claims, complaints, causes of action, grievances, liabilities, obligations, promises, damages, agreements, rights, debts and expenses (including
attorney’s fees and costs), of every kind, either at law or in equity, whether known or unknown, suspected or unsuspected, relating to my employment or separation from employment with Praxair, arising at any time up to and including the date of
the execution of this General Release. This includes any claims under any federal, state, local or municipal law, regulation or decision, including, but not limited to, claims arising under Title VII of the Civil Rights Acts of 1964 and 1991, the
Age Discrimination in Employment Act, the Americans with Disabilities Act of 1990, the Family and Medical Leave Act, any applicable Executive Order Programs, the Fair Labor Standards Act, or their state or local counterparts, as well as any common
law claims, including but not limited to claims for discrimination, retaliation, wrongful discharge, breach of contract, infliction of emotional distress, defamation, negligent hiring and/or supervision, or any allegation or claim arising under any
policies, practices or procedures of Praxair, or any public policy. It is expressly agreed and understood that this release is a GENERAL RELEASE. 
 2. I
acknowledge that: 
  

	 	(a)	I have read this document, and I understand its legal and binding effect. I am acting voluntarily and of my own free will in executing this release. 

  

	 	(b)	The consideration for this release is in addition to anything of value to which I already am entitled. 

  

	 	(c)	I have had the opportunity to seek and have consulted with legal counsel prior to signing this release. 

  

	 	(d)	I have been given at least 21 days to consider the terms of this release before signing it. In the event that I sign this release before the expiration of the 21-day period, I
acknowledge that I have freely chosen to waive the 21-day period. 

 3. I understand that if I sign this release, I can change my mind and
revoke it within seven days after signing it by sending a written revocation notice by overnight and certified mail to: 
 Praxair, Inc. 
 Vice President Human Resources 
 39 Old Ridgebury Rd. 
 Danbury, CT 06810 
  

 18 

 EXHIBIT A 
 I have read and understand the General Release set forth above and agree to be bound by its terms. 
 Signature:                                      
                               
 Name:
                                         
                                  
 Date:
                                         
                                    
  

 19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00153-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00153-of-00352.parquet"}]]